Treatment Registry
TR-0218 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Helimeds · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
Starter Dose (12-week supply)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“Starter Dose $447 one time payment SAVE $50 $149 / month”

$149Published figureCharged todayNot verified
Any other dose (12-week supply)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“Any other dose $697 one time payment SAVE $50 $232 / month”

$232Published figureCharged todayNot verified
Price sources
Visit Helimeds

We earn nothing from this link. It opens Helimeds's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
CancellationWhat if I need to cancel? To cancel, contact [email protected] . We offer flexible cancellation with no fees or long-term contract commitments.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from helimeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The site's /treatments/semaglutide page is titled 'Compounded GLP-1' and never actually uses the word 'semaglutide' in its visible text, so that product is recorded as unspecified GLP-1 rather than compounded semaglutide -- it does, however, explicitly say the '3 month supply of the medication will arrive in a single vial,' confirming injection-vial. The tirzepatide page never states vial vs pen. Footer branding is 'Travex Inc'; 'Helimeds' is the storefront brand name used throughout the visible copy.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0218
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Helimeds — compounded tirzepatide (TR-0218). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0218

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.